Lmr Partners LLP Selecta Biosciences Inc Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.15 - $1.89 $77,151 - $126,796	67,088 New	67,088 $93,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $1.4 $21,998 - $45,967	32,834 New	32,834 $43,000
Q4 2019 Feb 14, 2020	SELL	$1.32 - $2.47 $14,315 - $26,787	-10,845 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.79 - $3.05 $19,412 - $33,077	10,845 New	10,845 $19,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.